Nanosizing — Oral formulation development and biopharmaceutical evaluation

詳細情報 詳細情報について

• CRID

  1361699995927454208

• DOI

  10.1016/j.addr.2007.05.003

• ISSN

  0169409X

• Web Site

  https://api.elsevier.com/content/article/PII:S0169409X0700083X?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0169409X0700083X?httpAccept=text/plain

• データソース種別

  • Crossref